Natco Pharma Ltd.

Natco Pharma is currently trading at Rs. 2334.95, up by 52.90 points or 2.32% from its previous closing of Rs. 2282.05 on the BSE.

The scrip opened at Rs. 2310.00 and has touched a high and low of Rs. 2351.90 and Rs. 2310.00 respectively. So far 3184 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2709.00 on 07-Apr-2015 and a 52 week low of Rs. 1100.00 on 14-Aug-2014.

Last one week high and low of the scrip stood at Rs. 2520.00 and Rs. 2271.00 respectively. The current market cap of the company is Rs. 7584.36 crore.

The promoters holding in the company stood at 53.76%, while Institutions and Non-Institutions held 15.02% and 31.23% respectively.

Natco Pharma has received approval from Foreign Investment Promotion Board (FIPB) for increase of Foreign Investment Limit from 24% to 31.5% of the paid up equity share capital of the company. FIPB has also approved issue and allotment of eligible securities to Qualified Institutional Buyers (QIBs) up to Rs 450 crore.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.